nach oben

International Journal of Mental Health and Addiction

Erschienen in:

01.01.2009

Increased CSF Homocysteine in Pathological Gamblers Compared with Healthy Controls

verfasst von: Conny Nordin, Ingemar Sjödin

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Neurocognitive disturbances suggesting a frontal lobe dysfunction have been observed in pathological gamblers and alcohol dependents. Given that a high homocysteine level has been suggested to be a mediating factor in alcohol-related cognitive decline, we have determined homocysteine and cobalamine in cerebrospinal fluid (CSF) obtained from 11 pathological male gamblers and 11 healthy male controls. Compared with healthy controls, pathological gamblers displayed higher CSF levels of homocysteine while the opposite was the case with CSF cobalamine. Smoking decreased the levels of homocysteine while the concentrations of cobalamine were increased. Homocysteine is a sulphur-containing amino acid exerting cytotoxic effects in living cells. The metabolism of homocysteine to methionine is mediated by cobalamine and folate. Human studies suggest that homocysteine plays a role in brain damage and cognitive and memory decline. The relationship between pathological gambling, homocysteine, cobalamine, folate (not determined in the study) and cognitive processing warrants further investigation.

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association.

American Psychiatric Association (2005). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association.

Bergh, C., Eklundh, T., Södersten, P., & Nordin, C. (1997). Altered dopamine function in pathological gambling. Psychological Medicine, 27, 473–475. doi:10.1017/S0033291796003789.PubMedCrossRef

Blanco, C., Ibanez, A., Saiz-Ruiz, J., Blanco-Jerez, C., & Nunes, E. (2000). Epidemiology, pathophysiology and treatment of pathological gambling. CNS Drugs, 13, 397–407. doi:10.2165/00023210-200013060-00002.CrossRef

Cloninger, R., Przybeck, T., Svrakic, D., & Wetzel, R. (1994). The Temperament and Character Inventory (TCI): A Guide for its Development and Use. St. Louis: Center for Psychobiology of Personality.

Erdemir, E. O., & Bergstrom, J. (2006). Relationship between smoking and folic acid, vitamin B₁₂ and some haematological variables in patients with chronic periodontal disease. Journal of Clinical Periodontology, 33, 878–884. doi:10.1111/j.1600-051X.2006.01003.x.PubMedCrossRef

Erdemir, E. O., & Bergstrom, J. (2007). Effect of smoking on folic acid and vitamin B₁₂ after nonsurgical periodontal intervention. Journal of Clinical Periodontology, 34, 1074–1081. doi:10.1111/j.1600-051X.2007.01154.x.PubMedCrossRef

First, M., Gibbon, M., Spitzer, R., & Williams, J. (1997a). Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Washington D.C: American Psychiatric Press.

First, M., Gibbon, M., Spitzer, R., Williams, J., & Benjamin, L. (1997b). Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington D.C.: American Psychiatric Press.

Goudriaan, A. E., Oosterlaan, J., de Beurs, E., & van den Brink, W. (2006). Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction, 101, 534–547. doi:10.1111/j.1360-0443.2006.01380.x.PubMedCrossRef

Haidemenos, A., Kontis, D., Gazi, A., Kallai, E., Allin, M., & Lucia, B. (2007). Plasma homocysteine, folate and B₁₂ in chronic schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 1289–1296. doi:10.1016/j.pnpbp.2007.05.011.CrossRef

Herrmann, W., & Obeid, R. (2007). Biomarkers of folate and vitamin B12 status in cerebrospinal fluid. Clinical Cchemistry and Laboratory Medicine, 45, 1614–1620. doi:10.1515/CCLM.2007.310.CrossRef

Hill, T., & Lewicki, P. (2006). Statistics. Methods and Applications. A Comprehensive Reference for Science, Industry, and Data Mining. Tulsa: StatSoft.

Hyland, K., & Bottiglieri, T. (1992). Measurement of total plasma and cerebrospinal fluid homocysteine by fluorescence following high-performance liquid chromatogrtaphy and precolumn derivatization with o-phthaldialdehyde. J Chromatogr A, 579, 55–62. doi:10.1016/0378-4347(92)80362-T.CrossRef

Iancu, I., Lowengrub, K., Dembinsky, Y., Kotler, M., & Dannon, P. (2008). Pathological gambling: an update on neuropathophysiology and pharmacotherapy. CNS Drugs, 22, 123–138. doi:10.2165/00023210-200822020-00004.PubMedCrossRef

Ikeda, T., Funikawa, Y., Mashimoto, T., Takahashi, K., & Yamada, M. (1990). Vitamin B12 levels in serum and CSF of people with Alzheimers disease. Acta Psychiatrica Scandinavica, 82, 327–329. doi:10.1111/j.1600-0447.1990.tb01395.x.PubMedCrossRef

Lehmann, M., Regland, B., Blennow, K., & Gottfries, C. G. (2003). Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 16, 145–150. doi:10.1159/000071002.PubMedCrossRef

McCaddon, A. (2006). Homocysteine and cognition–a historical perspective. Journal of Alzheimer’s Disease, 9, 361–380.PubMed

Moretti, R., Terre, P., Antonello, R., Cattaruzza, T., Cazzato, G., & Bava, A. (2004). Vitamin B12 and folate depletion in cognition: a review. Neurol India, 52, 310–318.PubMed

Nijst, T., Wevers, R. A., Schoonderwaldt, H. C., Hommes, O. R., & de Haan, A. F. (1990). Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia. Journal of Neurology, Neurosurgery and Psychiatry, 53, 951–954.CrossRef

Nordin, C., & Eklundh, T. (1999). Altered CSF 5-HIAA disposition in pathologic male gamblers. CNS Spectrums, 4, 25–33.PubMed

Nordin, C., Gupta, R. C., & Sjödin, I. (2007). Cerebrospinal fluid amino acids in pathological gamblers and healthy controls. Neuropsychobiology, 56, 152–158. doi:10.1159/000115782.PubMedCrossRef

Nordin, C., & Nylander, P. O. (2007). Temperament and character in pathological gambling. Journal of Gambling Studies, 23, 113–120. doi:10.1007/s10899-006-9049-x.PubMedCrossRef

Nordin, C., & Sjödin, I. (2006a). Altered CSF taurine function in pathological gamblings. Journal of Psychiatric Research, 40, 473–474. doi:10.1016/j.jpsychires.2005.10.007.PubMedCrossRef

Nordin, C., & Sjödin, I. (2006b). CSF monoamine pattern in pathological gamblers and healthy controls. Journal of Psychiatric Research, 40, 454–459. doi:10.1016/j.jpsychires.2005.06.003.PubMedCrossRef

Nordin, C., & Sjödin, I. (2007). CSF cholecystokinin, γ-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls. Journal of Neural Transmission, 114, 499–503. doi:10.1007/s00702-006-0593-4.PubMedCrossRef

Obeid, R., Kasoha, M., Knapp, J.-P., Kostopoulos, P., Becker, G., Fassbender, K., et al. (2007a). Folate and methylation status in relation to phosphorylated tau protein (181P) and beta-amuloid (1–42) in cerebrospinal fluid. Clinical Chemistry, 53, 1129–1136. doi:10.1373/clinchem.2006.085241.PubMedCrossRef

Obeid, R., McCaddon, A., & Herrman, W. (2007b). The role of hyperhomocysteinemia amd B-vitamin deficiency in neurological and psychiatric diseases. Clinical Cchemistry and Laboratory Medicine, 45, 1590–1606. doi:10.1515/CCLM.2007.356.CrossRef

Patterson 2nd, J., Holland, J., & Middleton, R. (2006). Neuropsychological performance, impulsivity, and comorbid psychiatric illness in patients with pathological gambling undergoing treatment at the CORE inpatient Treatment Center. South Med J, 99, 36–43. doi:10.1097/01.smj.0000197583.24072.f5.PubMedCrossRef

Potenza, M. N., Fiellin, D., Heninger, G. R., Rounsaville, B. J., & Mazure, C. M. (2002). Gambling. An addictive behavior with health and primary care implications. Journal of General Internal Medicine, 17, 721–732. doi:10.1046/j.1525-1497.2002.10812.x.PubMedCrossRef

Raylu, N., & Oei, T. (2002). Pathological gambling. A comprehensive review. Clinical Psychology Review, 22, 1009–1061. doi:10.1016/S0272-7358(02)00101-0.PubMedCrossRef

Regland, B., Abrahamsson, L., Blennow, K., Grenfeldt, K., & Gottfries, C.-G. (2004). CSF-methionine is elevated in psychotic patients. Journal of Neural Transmission, 111, 631–640. doi:10.1007/s00702-004-0128-9.PubMedCrossRef

Roy, A., Adinoff, B., Roerich, L., Lamparski, D., Custer, R., Lorenz, V., et al. (1988). Pathological gambling. A psychobiological study. Archives of General Psychiatry, 45, 369–373.PubMed

Rugle, L., & Melamed, L. (1993). Neuropsychological assessment of attention problems in pathological gamblers. J Nerv Ment Dis, 181, 107–112. doi:10.1097/00005053-199302000-00006.PubMedCrossRef

Russo, C., Morabito, F., Luise, F., Piromalli, A., Battaglia, L., Vinci, A., et al. (2007). Hyperhomoyateinemia is associated with cognitive impairment in multiple sclerosis. Journal of Neurology, 255, 64–69. doi:10.1007/s00415-007-0668-7.PubMedCrossRef

Sakuta, H., & Suzuki, T. (2005). Alcohol consumption and plasma homocysteine. Alcohol, 37, 73–77. doi:10.1016/j.alcohol.2005.12.005.PubMedCrossRef

Wilhelm, J., Bayerlein, K., Hillemacher, T., Realbach, U., Frieling, H., Kromolan, B., et al. (2006). Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism. Journal of Neural Transmission, 113, 357–363. doi:10.1007/s00702-005-0333-1.PubMedCrossRef

Titel: Increased CSF Homocysteine in Pathological Gamblers Compared with Healthy Controls
verfasst von: Conny Nordin
Ingemar Sjödin
Publikationsdatum: 01.01.2009
Verlag: Springer-Verlag
Erschienen in: International Journal of Mental Health and Addiction / Ausgabe 1/2009
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-008-9172-2

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Gambling Trends in the State of New Mexico: 1996–1998

The Use of Social Marketing to Influence the Development of Problem Gambling in the UK: Implications for Public Health

Editorial: Gambling Research

Gambling Awareness for Youth: An Analysis of the “Don’t Gamble Away our Future™” Program

Congruence Couple Therapy for Pathological Gambling